Angiotensin receptor-neprilysin inhibiton (ARNI) - A novel therapeutic concept for management of hypertension and heart failure

被引：8
|
作者：
Kjeldsen, Sverre E. [1 ]
Hedner, Thomas [2 ]
Narkiewicz, Krzysztof [3 ]
Oparil, Suzanne [4 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, N-0407 Oslo, Norway
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Med, Gothenburg, Sweden
[3] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[4] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL USA
来源：
BLOOD PRESSURE | 2012年 / 21卷 / 06期
关键词：
NATRIURETIC-PEPTIDE; SYSTEM; BIOLOGY; TARGET; LCZ696;
D O I：
10.3109/10582452.2012.741765
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 40 条
  • [21] The Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor (ARNI) With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial
    McMurray, John J.
    Packer, Milton
    Desai, Akshay
    Gong, Jim
    Lefowitz, Marty
    Rizkala, Adel
    Rouleau, Jean
    Shi, Victor
    Solomon, Scott
    Swedberg, Karl
    Zile, Michael
    CIRCULATION, 2014, 130 (23) : 2114 - 2114
  • [22] Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact
    Buggey, Jonathan
    Mentz, Robert J.
    Devore, Adam D.
    Velazquez, Eric J.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (09) : 741 - 750
  • [23] The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : 1029 - 1041
  • [24] Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction
    Nasrallah, Dima
    Abdelhamid, Alaa
    Tluli, Omar
    Al-Haneedi, Yaman
    Dakik, Habib
    Eid, Ali H.
    PHARMACOLOGICAL RESEARCH, 2024, 204
  • [25] Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis
    Nguyen, Dung Viet
    Le, Thanh Ngoc
    Truong, Binh Quang
    Nguyen, Hoai Thi Thu
    EUROPEAN JOURNAL OF HEART FAILURE, 2025, 27 (01) : 72 - 84
  • [26] LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
    Suematsu, Yasunori
    Miura, Shin-ichiro
    Goto, Masaki
    Matsuo, Yoshino
    Arimura, Tadaaki
    Kuwano, Takashi
    Imaizumi, Satoshi
    Iwata, Atsushi
    Yahiro, Eiji
    Saku, Keijiro
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (04) : 386 - 393
  • [27] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor (vol 56, pg 1461, 2017)
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 105 - 123
  • [28] Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
    Packer, Milton
    McMurray, John J. V.
    Desai, Akshay S.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael
    Andersen, Karl
    Arango, Juan Luis
    Arnold, J. Malcolm
    Belohlavek, Jan
    Bohm, Michael
    Boytsov, Sergey
    Burgess, Lesley J.
    Cabrera, Walter
    Calvo, Carlos
    Chen, Chen-Huan
    Dukat, Andrej
    Duarte, Yan Carlos
    Erglis, Andrejs
    Fu, Michael
    Gomez, Efrain
    Gonzalez-Medina, Angel
    Hagege, Albert A.
    Huang, Jun
    Katova, Tzvetana
    Kiatchoosakun, Songsak
    Kim, Kee-Sik
    Kozan, Oemer
    Llamas, Edmundo Bayram
    Martinez, Felipe
    Merkely, Bela
    Mendoza, Ivan
    Mosterd, Arend
    Negrusz-Kawecka, Marta
    Peuhkurinen, Keijo
    Ramires, Felix J. A.
    Refsgaard, Jens
    Rosenthal, Arvo
    Senni, Michele
    Sibulo, Antonio S., Jr.
    Silva-Cardoso, Jose
    Squire, Iain B.
    Starling, Randall C.
    Teerlink, John R.
    Vanhaecke, Johan
    CIRCULATION, 2015, 131 (01) : 54 - 61
  • [29] Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM
    Lillyblad, Matthew P.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (11) : 1237 - 1251
  • [30] Angiotensin II Receptor Blocker (ARB) in Combination With Neprilysin Inhibition is Superior to ARB Alone in the Setting of Heart Failure
    Trivedi, Rishi K.
    Polhemus, David J.
    Li, Zhen
    Yoo, Daniel
    Koiwaya, Hiroshi
    Zibilich, Craig
    Goodchild, Traci T.
    Lefer, David J.
    CIRCULATION, 2017, 136
1234